Back to results
US 2015/0175603 A1Published application
Tricyclic compounds as kat ii inhibitors
AssigneePfizer Inc.
InventorsAmy Beth Dounay, Jamison Bryce Tuttle, Patrick Robert Verhoest
Life of this patent
Estimating the term…
Abstract
Compounds of Formula (I), wherein R1, R2, X1, Y1, Z1, and Z2 are as defined herein, and pharmaceutically acceptable salts thereof, are described as useful for the treatment of cognitive deficits associated with schizophrenia and other psychiatric, neurodegenerative and/or neurological disorders in mammals, including humans.
Claims24
A compound of Formula I:
- or a pharmaceutically acceptable salt thereof, wherein:
- represents a single bond or a double bond;
- X1 is CR3 or N;
- Y1 is CR4 or N;
- Z1 is CR5 or C(═O);
- Z2 is N, NH, or O;
- R1 is Q1, —O-Q1, or —CH2-Q1;
- R2 is H, OH, —CN, halogen, optionally substituted C1-4 alkyl, or optionally substituted C1-4 alkoxy;
- each of R3 and R4 is independently H, OH, —CN, halogen, optionally substituted C1-4 alkyl, or optionally substituted C1-4 alkoxy;
- R5 is H, OH, —CN, C1-3 alkyl optionally substituted with one or more halogen, or C1-3 alkoxy optionally substituted with one or more halogen;
- and
- Q1 is optionally substituted phenyl or optionally substituted 5- to 10-membered heteroaryl.
9 more elements
A compound of Formula Ia, Ib, or Ic:
- or a pharmaceutically acceptable salt thereof, wherein:
- X1 is CR3 or N;
- Y1 is CR4 or N;
- R1 is Q1, —O-Q1, or —CH2-Q1;
- R2 is H, OH, —CN, halogen, optionally substituted C1-4 alkyl, or optionally substituted C1-4 alkoxy;
- each of R3 and R4 is independently H, OH, —CN, halogen, optionally substituted C1-4 alkyl, or optionally substituted C1-4 alkoxy;
- R5 is H, OH, —CN, C1-3 alkyl optionally substituted with one or more halogen, or C1-3 alkoxy optionally substituted with one or more halogen;
- and
- Q1 is optionally substituted phenyl or optionally substituted 5- to 10-membered heteroaryl.
6 more elements
(canceled)
7-8. (canceled)
A compound of Formula Ia-1, Ia-2, Ib-1, Ib-2, Ib-3, or Ic-1:
- or a pharmaceutically acceptable salt thereof, wherein:
- R1 is Q1, —O-Q1, or —CH2-Q1;
- R3 is H, OH, —CN, halogen, optionally substituted C1-4 alkyl, or optionally substituted C1-4 alkoxy;
- and
- Q1 is optionally substituted phenyl or optionally substituted 5- to 10-membered heteroaryl.
2 more elements
(canceled)
(canceled)
Dependencies are inferred from the claim text.